Gallagher WM - Search Results

1

Breast cancer proteomics: clinical perspectives.

Lau TY, O'Connor DP, Brennan DJ, Duffy MJ, Pennington SR, Gallagher WM. Lau TY, et al. Among authors: gallagher wm. Expert Opin Biol Ther. 2007 Feb;7(2):209-19. doi: 10.1517/14712598.7.2.209. Expert Opin Biol Ther. 2007. PMID: 17250459 Review.

2

Elevated expression and altered processing of fibulin-1 protein in human breast cancer.

Greene LM, Twal WO, Duffy MJ, McDermott EW, Hill AD, O'Higgins NJ, McCann AH, Dervan PA, Argraves WS, Gallagher WM. Greene LM, et al. Among authors: gallagher wm. Br J Cancer. 2003 Mar 24;88(6):871-8. doi: 10.1038/sj.bjc.6600802. Br J Cancer. 2003. PMID: 12644824 Free PMC article.

3

Application of DNA microarray technology in determining breast cancer prognosis and therapeutic response.

Brennan DJ, O'Brien SL, Fagan A, Culhane AC, Higgins DG, Duffy MJ, Gallagher WM. Brennan DJ, et al. Among authors: gallagher wm. Expert Opin Biol Ther. 2005 Aug;5(8):1069-83. doi: 10.1517/14712598.5.8.1069. Expert Opin Biol Ther. 2005. PMID: 16050784 Review.

4

Surface-induced changes in protein adsorption and implications for cellular phenotypic responses to surface interaction.

Allen LT, Tosetto M, Miller IS, O'Connor DP, Penney SC, Lynch I, Keenan AK, Pennington SR, Dawson KA, Gallagher WM. Allen LT, et al. Among authors: gallagher wm. Biomaterials. 2006 Jun;27(16):3096-108. doi: 10.1016/j.biomaterials.2006.01.019. Epub 2006 Feb 7. Biomaterials. 2006. PMID: 16460797

5

Proteomic analysis of factors released from p21-overexpressing tumour cells.

Currid CA, O'Connor DP, Chang BD, Gebus C, Harris N, Dawson KA, Dunn MJ, Pennington SR, Roninson IB, Gallagher WM. Currid CA, et al. Among authors: gallagher wm. Proteomics. 2006 Jul;6(13):3739-53. doi: 10.1002/pmic.200500787. Proteomics. 2006. PMID: 16739131

6

Molecular basis of cell-biomaterial interaction: insights gained from transcriptomic and proteomic studies.

Gallagher WM, Lynch I, Allen LT, Miller I, Penney SC, O'Connor DP, Pennington S, Keenan AK, Dawson KA. Gallagher WM, et al. Biomaterials. 2006 Dec;27(35):5871-82. doi: 10.1016/j.biomaterials.2006.07.040. Epub 2006 Aug 28. Biomaterials. 2006. PMID: 16938344

7

CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.

Brennan DJ, Jirstrom K, Kronblad A, Millikan RC, Landberg G, Duffy MJ, Rydén L, Gallagher WM, O'Brien SL. Brennan DJ, et al. Among authors: gallagher wm. Clin Cancer Res. 2006 Nov 1;12(21):6421-31. doi: 10.1158/1078-0432.CCR-06-0480. Clin Cancer Res. 2006. PMID: 17085655 Clinical Trial.

8

CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer.

O'Brien SL, Fagan A, Fox EJ, Millikan RC, Culhane AC, Brennan DJ, McCann AH, Hegarty S, Moyna S, Duffy MJ, Higgins DG, Jirström K, Landberg G, Gallagher WM. O'Brien SL, et al. Among authors: gallagher wm. Int J Cancer. 2007 Apr 1;120(7):1434-43. doi: 10.1002/ijc.22413. Int J Cancer. 2007. PMID: 17205517 Free PMC article.

9

Survivin: a promising tumor biomarker.

Duffy MJ, O'Donovan N, Brennan DJ, Gallagher WM, Ryan BM. Duffy MJ, et al. Among authors: gallagher wm. Cancer Lett. 2007 Apr 28;249(1):49-60. doi: 10.1016/j.canlet.2006.12.020. Epub 2007 Feb 1. Cancer Lett. 2007. PMID: 17275177 Review.

10

DNA microarray-based transcriptomic profiling of an isogenic cell culture model of breast tumour cell invasion.

Hughes L, O'Brien SL, Gallagher WM, Mcdonnell S. Hughes L, et al. Among authors: gallagher wm. Anticancer Res. 2007 May-Jun;27(3A):1353-9. Anticancer Res. 2007. PMID: 17593630 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters